Dynamic Control of 4-Hydroxyisoleucine Biosynthesis by Modified l-Isoleucine Biosensor in Recombinant .

4-Hydroxyisoleucine (4-HIL), a promising drug for treating diabetes, can be synthesized from the self-produced l-isoleucine (Ile) by expressing the Ile dioxygenase gene in . However, the requirement of three substrates, Ile, α-ketoglutarate (α-KG), and O, makes such biosynthesis difficult to be fulfilled effectively under static engineering conditions. In this study, dynamic control of 4-HIL biosynthesis by the Ile biosensor Lrp-P was researched. The native P promoter of natural Ile biosensor was still weak even under Ile induction. Through dual genetic selection, several modified stronger PN promoters were obtained from the synthetic library of the Ile biosensor. Dynamic regulation of expression by modified Ile biosensors increased the 4-HIL titer from 24.7 mM to 28.9-74.4 mM. The best strain ST04 produced even a little more 4-HIL than the static strain SN02 overexpressing by the strong P promoter (69.7 mM). Further dynamic modulation of α-KG supply in ST04 by expressing different PN-controlled decreased the 4-HIL production but increased the l-glutamate or Ile accumulation. However, synergistic modulation of α-KG supply and O supply in ST04 by different combinations of PN- and PN- improved the 4-HIL production significantly, and the highest titer (135.3 mM) was obtained in ST17 strain regulating all the three genes by P7. This titer was higher than those of all the static metabolic engineered strains ever constructed. Therefore, dynamic regulation by modified Ile biosensor is a predominant strategy for enhancing 4-HIL biosynthesis in .